Company: LGN
Filing Date: 2025-02-14
Form Type: DRS
Source: 0000950123-25-002471
Chunk: 18

Company: Legence Corp.
Filing Date: 2025-02-14
Form: DRS
Chunk 18
---
 website is not incorporated by reference herein and does not constitute a part of this
prospectus.

9

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83

The Offering

| Class A Common Stock offered by us | shares (or      shares, if the underwriters exercise in full their option to purchase additional shares). |

| Option to purchase additional shares | We have granted the underwriters a 30-day option to purchase up to an aggregate of      additional shares of our Class A Common Stock. |

| Class A Common Stock to be outstanding after the offering | shares (or      shares, if the underwriters exercise in full their option to purchase additional shares). |

| Class B Common Stock to be outstanding immediately after completion of this offering | shares (or      shares, if the underwriters exercise in full their option to purchase additional shares and after giving effect to the application of the net proceeds therefrom), or one share 
 for each LGN Unit held by the LGN Unit Holders immediately following this offering. Class B Common Stock is non-economic. When an LGN Unit is exchanged for a share of Class A Common Stock, a  
 corresponding share of Class B Common Stock will be surrendered.                                                                                                                                |

| Use of proceeds | We expect to receive approximately $   million of net proceeds from the sale of the Class A Common Stock offered by us, assuming an initial public offering price of $   per share, which is the midpoint of the price                                
 range on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering expenses payable by us. A $1.00 increase (decrease) in the assumed initial public offering price of $   per share           
 would increase (decrease) the net proceeds to us from the sale of the Class A Common Stock offered by us by $   million, assuming the number of shares offered by us, as set forth on the cover page of this prospectus, remains the                  
 same, after deducting estimated underwriting discounts and commissions and estimated offering expenses. Similarly, an increase (decrease) of one million shares in the number of shares sold in this offering by us would increase (decrease) the net 
 proceeds to us from this offering by $   million, assuming